Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Francesca Alvarez Calderon, M.D., Ph.D.

Concepts (84)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Francesca Alvarez Calderon's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Francesca Alvarez Calderon has written about over time.
Fusion Proteins, bcr-abl, 2 publications between 2010 and 2014, average publication date October 2012. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 2 publications between 2010 and 2014, average publication date October 2012. RNA, Small Interfering, 4 publications between 2010 and 2016, average publication date November 2013. RNA Interference, 2 publications between 2013 and 2014, average publication date January 2014. Protein Kinase Inhibitors, 3 publications between 2010 and 2016, average publication date February 2014. Mice, Inbred NOD, 3 publications between 2013 and 2016, average publication date December 2014. Drug Resistance, Neoplasm, 2 publications between 2013 and 2016, average publication date December 2014. Dihydrolipoyllysine-Residue Acetyltransferase, 1 publications between 2014 and 2014, average publication date December 2014. Ketone Oxidoreductases, 1 publications between 2014 and 2014, average publication date December 2014. Mitochondrial Proton-Translocating ATPases, 1 publications between 2014 and 2014, average publication date December 2014. Oligomycins, 1 publications between 2014 and 2014, average publication date December 2014. Mitochondria, 2 publications between 2014 and 2015, average publication date January 2015. Protein-Tyrosine Kinases, 2 publications between 2014 and 2015, average publication date January 2015. fms-Like Tyrosine Kinase 3, 2 publications between 2014 and 2016, average publication date November 2015. Hematologic Neoplasms, 2 publications between 2013 and 2024, average publication date September 2018. Neoplasms, 2 publications between 2015 and 2024, average publication date September 2019. Immunity, Cellular, 1 publications between 2024 and 2024, average publication date March 2024. NK Cell Lectin-Like Receptor Subfamily B, 1 publications between 2024 and 2024, average publication date March 2024. Antigen-Presenting Cells, 1 publications between 2024 and 2024, average publication date October 2024. OX40 Ligand, 1 publications between 2024 and 2024, average publication date October 2024.

To see the data from this visualization as text, click here.
Alvarez Calderon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (84)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.